AI to Improve Cardiology Care
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests whether large language models (a type of AI that understands human language) can help cardiologists give better care. If you are a qualified cardiologist who currently treats patients, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a board certified or board eligible cardiologist.
- You must currently be seeing patients in a clinical setting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to help diagnose and predict outcomes for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes thickened. It may help doctors better understand your condition and plan your care.
This study uses artificial intelligence (AI) to look at heart CT scans (coronary CT angiograms) to help spot different types of cardiomyopathy (diseases of the heart muscle) earlier and more accurately. If you have a cardiomyopathy and have had a heart CT scan before any surgery or device placement, this study may help improve diagnosis and treatment planning.
This study at Mayo Clinic is testing an artificial intelligence (AI) tool that analyzes echocardiograms (ultrasound of the heart) to find early signs of four types of heart muscle disease. If the AI flags a high-risk pattern, doctors can learn whether acting on that alert helps catch the condition sooner.
This study tests whether a new AI tool can help primary care doctors better manage chronic conditions in their community practice. You might join if you're a doctor with at least 3 years of experience working at a local health center.
This study tests whether messages from a large language model (a type of AI) can help doctors prescribe the right medicines for heart failure. It may help people with heart failure get the best guideline-recommended treatments.
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.